Drug developer Cephalon Inc. expects to continue building its market share in fatigue and pain treatments while focusing on expanding the uses for sleepiness and fatigue treatment Nuvigil before launching the product.
From: biz.yahoo.com
Cephalon Focuses on Expanding Labels
Posted by Ruslan Abuzant at 10:20 AM
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment